Genomic Characterization of KPC-31 and OXA-181 <i>Klebsiella pneumoniae</i> Resistant to New Generation of β-Lactam/β-Lactamase Inhibitor Combinations
Background: Carbapenem resistant <i>Klebsiella pneumoniae</i> (cr-Kp) causes serious infections associated with a high mortality rate. The clinical efficacy of ceftazidime/avibactam (CZA), meropenem/vaborbactam (M/V), and imipenem/relebactam (I/R) against cr-Kp is challenged by the emerg...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/12/1/10 |